Establishment of a chemical synthetic lethality screen in cultured human cells

被引:38
作者
Simons, A
Dafni, N
Dotan, I
Oron, Y
Canaani, D [1 ]
机构
[1] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Biochem, IL-69978 Ramat Aviv, Israel
[2] Tel Aviv Univ, Sackler Fac Med, Dept Physiol & Pharmacol, IL-69978 Ramat Aviv, Israel
关键词
D O I
10.1101/gr.154201
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The synthetic lethality screen is a powerful genetic method for unraveling functional interactions between proteins in yeast. Here we demonstrate the feasibility of a chemical synthetic lethality screen in cultured human cells, based in part on the concept of the yeast method. The technology employs both an immortalized human cell line, deficient in a gene of interest, which is complemented by an episomal survival plasmid expressing the gene of interest, and the use of a novel double-label Fluorescence system. Selective pressure imposed by any one of several synthetic lethal metabolic inhibitors prevented the spontaneous loss of the episomal survival plasmid. Retention or loss over time of this plasmid could be sensitively detected in a blind test, while cells were grown in microtiter plates. Application of this method should thus permit high throughput screening of drugs, which al-e synthetically lethal with any mutant human gene of interest, whose normal counterpart can be expressed. This usage is particularly attractive for the search of drugs, which kill malignant cells in a gene-specific manner, based on:their predetermined cellular genotype. Moreover, by replacing the chemicals used in this example with a library of either DNA oligonucleotides or expressible dominant negative genetic elements, one should be able to identify synthetic lethal human genes.
引用
收藏
页码:266 / 273
页数:8
相关论文
共 32 条
[1]   Antisense therapeutics [J].
Agrawal, S ;
Zhao, QY .
CURRENT OPINION IN CHEMICAL BIOLOGY, 1998, 2 (04) :519-528
[2]   USE OF A SCREEN FOR SYNTHETIC LETHAL AND MULTICOPY SUPPRESSEE MUTANTS TO IDENTIFY 2 NEW GENES INVOLVED IN MORPHOGENESIS IN SACCHAROMYCES-CEREVISIAE [J].
BENDER, A ;
PRINGLE, JR .
MOLECULAR AND CELLULAR BIOLOGY, 1991, 11 (03) :1295-1305
[3]  
BENEDICT WF, 1984, CANCER RES, V44, P3471
[4]   INVENTING AND IMPROVING RIBOZYME FUNCTION - RATIONAL DESIGN VERSUS ITERATIVE SELECTION METHODS [J].
BREAKER, RR ;
JOYCE, GF .
TRENDS IN BIOTECHNOLOGY, 1994, 12 (07) :268-275
[5]   The potential of extrachromosomal replicating vectors for gene therapy [J].
Calos, MP .
TRENDS IN GENETICS, 1996, 12 (11) :463-466
[6]   14-3-3σ is required to prevent mitotic catastrophe after DNA damage [J].
Chan, TA ;
Hermeking, H ;
Lengauer, C ;
Kinzler, KW ;
Vogelstein, B .
NATURE, 1999, 401 (6753) :616-620
[7]   Genetic selection of peptide aptamers that recognize and inhibit cyclin-dependent kinase 2 [J].
Colas, P ;
Cohen, B ;
Jessen, T ;
Grishina, I ;
McCoy, J ;
Brent, R .
NATURE, 1996, 380 (6574) :548-550
[8]   The impact of genomics on drug discovery [J].
Debouck, C ;
Metcalf, B .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2000, 40 :193-207
[9]   A GENETIC TOOL USED TO IDENTIFY THIOREDOXIN AS A MEDIATOR OF A GROWTH INHIBITORY SIGNAL [J].
DEISS, LP ;
KIMCHI, A .
SCIENCE, 1991, 252 (5002) :117-120
[10]   The future is function [J].
Fields, S .
NATURE GENETICS, 1997, 15 (04) :325-327